Ingersoll Rand (NYSE:IR) schedules its next earnings release and conference call as the S&P 500 industrial equipment company ...

EMERGE is a global, randomized, multicenter, placebo-controlled Phase 3 trial that will evaluate claseprubart 300mg/2mL S.C. dosed Q2W and Q4W vs. placebo, with top-line results anticipated in 2H'28 ...

Middle East producers are pushing ahead with oil ​and liquefied natural gas loading despite fresh ship attacks in the Strait ...

The Detroit Lions are still learning what they have in running back Sione Vaki. Originally a safety in college at Utah, Vaki did some work in the backfield during his collegiate career. When the Lions ...

AbbVie stock rallied today on the $10.9 billion acquisition of Apogee Therapeutics. Here’s how you should play ABBV shares at ...

Ashley Abramson is a writer-mom hybrid. Her work, mostly focused on health, psychology, and parenting, has been featured in the Washington Post, New York Times, Allure, and more. She lives in the ...

Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.

The last time I spoke about TG Therapeutics, Inc. (TGTX), it was with a Seeking Alpha article entitled "TG Therapeutics: 'Strong Buy' On BRIUMVI's Massive Growth And Possible Expansion." Regarding ...

Christina is a freelance writer, registered dietitian, and sustainable food systems professional. She feels most passionately about improving the health of the planet and its people through sharing ...

Wegovy is a GLP-1 medication that is prescribed to help with weight loss and weight management, to reduce cardiovascular risks, and to treat metabolic dysfunction-associated steatohepatitis (MASH).

If you're the parent of a baby or a young child, you’ve probably woken up in the middle of the night to find your child crying out in pain or sweating from a fever. This situation can be scary if you ...

The Food and Drug Administration approved a higher dose version of Novo Nordisk's blockbuster weight loss injection Wegovy, as the company pushes to win back market share from Eli Lilly. The high-dose ...